Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-01-26

Clinical Trial Update: Neuromodulation Implantation Settings Variation for Overactive Bladder [NA]

View source ↗

Summary

A clinical trial evaluating variations in neuromodulation implantation settings for overactive bladder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Loma Linda University | Conditions: Overactive Bladder | NA | Status: WITHDRAWN